Sentences with phrase «plasma cell cancer»

She has published journal articles and book chapters on topics including canine osteosarcoma, canine and feline liver tumors, and canine and feline plasma cell cancer / multiple myeloma.

Multiple myeloma is a rare, malignant plasma cell cancer affecting the bone marrow and other blood producing organs.

While the cause of MGUS and multiple myeloma (plasma cell cancer) remains largely unclear, studies have reported an elevated risk of multiple myeloma among farmers and other agricultural workers and pesticides have been thought to be the basis for these associations, according to study background.

Not exact matches

Vortex's system uses a microfluidic chip to generate tiny vortices that trap larger, more deformable cancer cells from a blood plasma sample.

«Starting with our cell model that mimics human pancreatic cancer progression, we identified released proteins, then tested and validated a subset of these proteins as potential plasma biomarkers of this cancer,» Zaret said.

Multiple myeloma is a cancer that affects plasma cells.

Healthy plasma cells produce antibodies that fight infection in the body, but myeloma cells produce high levels of abnormal antibodies that, when the cancer cells accumulate, they crowd out production of other important blood cells, both red and white.

Being overweight or obese has been known to increase the risk of multiple myeloma, a cancer of the plasma cells in the blood and bone marrow that develops more often after age 60.

Multiple myeloma is a cancer of plasma cells in the blood that causes tumor growths in bone marrow.

Epidermal growth factor receptor (EGFR) mutations found in the circulating free tumor DNA (ctDNA) from the plasma of advanced non-small cell lung cancer (NSCLC) patients correlates well with the EGFR mutations from patient - matched tumor tissue DNA.

In a related editorial, Niklhil C. Munshi, M.D., of the Dana - Farber Cancer Institute, Boston, writes: «The study by Landgren et al has brought clarity to the risk of AO [Agent Orange] exposure and plasma cell disorder.

Multiple myeloma is a cancer of the infection - fighting plasma cells, part of the immune system found mainly in bone marrow.

In the 1990s the U.S. Food and Drug Administration approved its use in the treatment of both multiple myeloma (a form of cancer that affects plasma cells) and the complications of leprosy.

Although myeloma is, like leukemias and lymphomas, a cancer involving white blood cells known as lymphocytes, myeloma cells don't traditionally express CD19 on their surface because they arise from the most mature type of lymphocytes — plasma cells.

«There was some skepticism about whether a CD19 - directed therapy would work in this disease, since nearly all of these patients» cancerous plasma cells do not express CD19,» said the study's senior author, Edward Stadtmauer, MD, chief of Hematologic Malignancies and a professor of Hematology / Oncology in Penn's Abramson Cancer Center and Perelman School of Medicine.

Multiple myeloma is a blood cancer that forms in a type of white blood cell called a plasma cell.

The laboratory primarily studies multiple myeloma, a cancer of plasma cells.

Cancers of the breast, prostate, colorectal system, liver and kidney as well as multiple myeloma, a cancer of the plasma cells that make antibodies to fight viruses and bacteria, strike earlier, deadlier and more often in some racial and ethnic groups, the National Cancer Institute has cancer of the plasma cells that make antibodies to fight viruses and bacteria, strike earlier, deadlier and more often in some racial and ethnic groups, the National Cancer Institute has Cancer Institute has shown.

Circulating cell - free DNA (cfDNA) isolated from plasma or serum by noninvasive procedures can serve as a «liquid biopsy» and has potential as a biomarker for the tumor burden and survival prediction of breast cancer (BC).

A research team led by Prof. Dr. Prasad Shastri at the University of Freiburg has shown that the stiffness of the cancer cell plasma membrane affects how nanoparticles are internalized, and this process can be enhanced when the cell plasma membrane stiffness is increased.

Myeloma — also referred to as multiple myeloma or plasma cell myeloma — is a cancer that originates in plasma cells, a type of white blood cell that makes antibodies.

S100A11 is required for efficient plasma membrane repair and survival of invasive cancer cells.

Analysis of microbial sequences in plasma cell - free DNA for early - onset breast cancer patients and healthy females — Yu - Feng Huang — BMC Medical Genomics

Myeloma is a bone marrow cancer that starts in the plasma cells.

In this type of plasma cell neoplasm, less than 10 % of the bone marrow is made up of abnormal plasma cells and there is no cancer.

For more information from the National Cancer Institute about multiple myeloma and other plasma cell neoplasms, see the following:

The following types of plasma cell neoplasms are cancer:

«The plasma membrane also dynamically changes shape during cell migration, cancer cell invasion, cell division, nutrient uptake, and entry of pathogens and viruses into cells,» Shin explains.

DENVER — Three manuscripts published in the recent issue of the Journal of Thoracic Oncology, the official journal of the International Association for the Study of Lung Cancer (IASLC), explored the versatility of liquid biopsies by identifying EGFR mutations using circulating tumor DNA (ctDNA) in urine and plasma and examining circulating tumor cells (CTCs) in plasma to predict the risk of lung cancer recurrence after surgical reseCancer (IASLC), explored the versatility of liquid biopsies by identifying EGFR mutations using circulating tumor DNA (ctDNA) in urine and plasma and examining circulating tumor cells (CTCs) in plasma to predict the risk of lung cancer recurrence after surgical resecancer recurrence after surgical resection.

Myeloma — also referred to as multiple myeloma or plasma cell myeloma — is a cancer that originates in plasma cells, a type of white blood cell that make antibodies.

«A whole generation of cancer investigators, including me, has been taught that PTEN performs its crucial role at the plasma membrane, which is what separates the inside of cells from the outside environment» Trotman explains.

Multiple myeloma and other plasma cell neoplasms (cancers) are diseases in which the body makes too many plasma cells.

(a) The oxidative catabolism of free fatty acids and amino acids (via the Respiratory Chain and Citric Acid Cycle) might be inhibited in hypoxic cancer cells via the judicious use of agents which inhibit their availability, i.e., partially inhibit hepatic fatty acid synthesis and keep plasma amino acid levels within the normal range, thus decreasing ATP production;

Special Areas of Interest: Osteosarcoma, plasma cell tumors, lymphoma, mast cell tumors, and investigating ways in which the immune system can be modified to better recognize and eliminate cancer cells.

When lymphocytes and plasma cells are the predominant cell types the most likely underlying causes are sensitivities to dietary components (wheat gluten is one example), parasites, bacterial toxins, cancers, heritable tendencies (occurs in Basenjis and wheaten terriers), and again a big group of dogs where a specific underlying cause isn't identifiable, or the idiopathic cases.

This is the most effective delivery method, because it allows plasma concentrations of the vitamin to reach levels high enough to potentially kill cancer cells and offer other benefits.